Technical Program
Technical Program for the 6th International Conference on CRISPR Technologies.
To View Abstract for CRISPR Conference please
Start Time | End Time | |
October 17, 2023 | All Eastern Standard Time | |
Day 1 | ||
8:00 AM | 4:00 PM | Registration |
9:00 AM | 9:10 AM | Welcome Remarks by Chairs: Kristin Knouse, MIT, Andrew Anzalone, Prime Medicine, & Benjamin Kleinstiver, Harvard |
9:10 AM | 10:00 AM | KEYNOTE: Base editing and prime editing: correcting mutations that cause genetic disease in cells, animals, and patients, David Liu, Broad Institute |
10:00 AM | 10:30 AM | Morning Coffee Break Sponsored by Synthego |
10:30 AM | 12:25 PM | CRISPR Biology, Tools, and Applications; Session Chairs: Jonathan Strecker & Andrew Anzalone |
10:30 AM | 10:55 AM | Invited Speaker: CRISPR-like RNAs regulate expression of cas genes, Sergey Shmakov, NIH |
10:55 AM | 11:20 AM | Invited Speaker: Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering, Soumya Kannan, Broad Institute |
11:20 AM | 11:45 AM | Invited Speaker: Precision genome editing with DNA-dependent DNA polymerases and exogenous DNA-containing templates, Erik Sontheimer, University of Massachusetts |
11:45 AM | 12:05 PM | Selected Abstract: RNA-Guided Type V CRISPR Nucleases Are Small, Efficient Genome Editing Tools with Diverse Targeting Capabilities, Lisa M. Alexander, Metagenomi |
12:05 PM | 12:25 PM | Selected Abstract: Dynamics and Mechanics of R-Loop Formation during DNA Interrogation By Cas12a from Different Species, Kevin Aris, Stanford University |
12:25 PM | 1:25 PM | Lunch |
1:25 PM | 2:55 PM | Epigenetic and RNA editing Session Chairs: Morgan Maeder & Kristin Knouse |
1:25 PM | 1:50 PM | Invited Speaker: Unlocking OPERA Platform to Activate Transcription Factor, Venkat Krishnamurthy, Korro Bio |
1:50 PM | 2:15 PM | Invited Speaker: Enhancing Genome and Transcriptome Engineering: New Approaches, New Challenges, Prashant Mali, UC San Diego |
2:15 PM | 2:35 PM | Selected Abstract: Development of Cas12a for Multiplexed Genome-Scale Transcriptional Activation Yanjing Liu, The Broad Institute of MIT and Harvard |
2:35 PM | 2:55 PM | Selected Abstract: Next-Generation Epigenome Editors As Tools for Basic Discovery and Therapeutic Intervention, Edwin Neumann, MIT, Whitehead Institute for Biomedical Research |
2:55 PM | 3:25 PM | Afternoon Coffee Break |
3:25 PM | 5:20 PM | High-Throughput Functional Genomics Session Chairs: Kristin Knouse & Manda Arbab |
3:25 PM | 3:50 PM | Invited Speaker: CRISPR-based decoding of disease-associated genomic variants, Richard Sherwood, Brigham and Women's Hospital |
3:50 PM | 4:15 PM | Invited Speaker: Single-cell high-content screening via genomic perturbation profiling at scale, Paul Blainey, MIT and Broad Institute |
4:15 PM | 4:40 PM | Invited Speaker: Karyocreate: A CRISPR-based technology to study chromosome-specific aneuploify by targeting human centromeres, Teresa Davoli, NYU |
4:40 PM | 5:00 PM | Selected Abstract: Reprogramming Functional Transcription Factor Binding Sites in Regulatory DNA with Pooled Prime Editing, Michael Montgomery, Stanford University |
5:00 PM | 5:20 PM | Selected Abstract: Mapping the Genetic Interaction Network of PARP Inhibitor Response, Jia Ling, Princeton University |
5:20 PM | 6:20 PM | Poster Session 1 and Cocktail Reception Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism |
Start Time | End Time | |
October 18, 2023 | All Eastern Standard Time | |
Day 2 | ||
8:30 AM | 4:00 PM | Registration |
9:00 AM | 9:10 AM | Welcome Remarks by Chair: Andrew Anzalone, Prime Medicine |
9:10 AM | 10:00 AM | KEYNOTE: From reading the genome for risk to rewriting it for cardiovascular health, Sekar Kathiresan, Verve Therapeutics |
10:00 AM | 10:30 AM | Morning Coffee Break |
10:30 AM | 12:25 PM | Progress Towards The Clinic Session Chairs: Morgan Maeder & Manda Arbab |
10:30 AM | 10:55 AM | Invited Speaker: Correcting Pathogenic Mutations via Prime Editing, Gerald Schwank, University of Zurich |
10:55 AM | 11:20 AM | Invited Speaker: Base editing rescue of spinal muscular atrophy in cells and in mice, Mandana Arbab, Harvard Medical School |
11:20 AM | 11:45 AM | Invited Speaker: Modularity of In Vivo CRISPR Therapies, Jonathan Phillips, Intellia Tx |
11:45 AM | 12:05 PM | Selected Abstract: Gene Editing without Ex Vivo culture Evades Genotoxicity in Human Hematopoietic Stem Cells, Jing Zeng, Boston Children's Hospital |
12:05 PM | 12:25 PM | Selected Abstract: Rapid, Definitive Treatment of Phenylketonuria in Variant-Humanized Mice with Corrective Editing, Dominique Brooks, University of Pennsylvania |
12:25 PM | 1:55 PM | Lunch Workshop: Challenges for CNS Delivery Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism; Session Chair: Mandana Arbab & Ben Kleinstiver |
12:40 PM | 12:55 PM | Structure-activity relationships guided engineering of AAV capsids with optimized skeletal muscle, cardiac muscle, and CNS tropism, Charlie Albright, Affinia Therapeutics |
12:55 PM | 1:10 PM | Invited Speaker: Targeted Gene Regulation in the CNS Using Engineered Zinc Finger Protein Transcription Factors, Andrew Young, Sangamo Therapeutics |
1:10 PM | 1:25 PM | Invited Speaker: Teaching old AAVs new tricks: enhancing CNS gene delivery by engineering capsid-receptor interactions, Ben Deverman, Broad Institute of MIT |
1:25 PM | 1:50 PM | Round Table Panel Discussion led by Mandans & Ben; Panelists: Charlie Albright, Affinia Therapeutics, Andrew Young, Sangamo Therapeutics, Ben Deverman, Broad Institute of MIT, Samagya Banskota, Boston University |
1:55 PM | 3:30 PM | Advances In Delivery Session Chairs: Matt Stanton & Kristin Knouse |
1:55 PM | 2:20 PM | Invited Speaker: Efficient prime editing in mouse brain, liver and heart with dual AAVs, Samagya Banskota, Boston University |
2:20 PM | 2:45 PM | Invited Speaker: Addressing key challenges for non-viral DNA delivery, Matt Stanton, Generation Bio |
2:45 PM | 3:10 PM | Invited Speaker: Targeted LNP-RNA: an evolving modality for gene editing, Hamideh Parhiz, UPenn |
3:10 PM | 3:30 PM | Selected Abstract: Quantifying how dozens of LNPs deliver mRNA in vivo with single-cell resolution using multiomics, Hyejin Kim, Georgia Institute of Technology/Emory University |
3:30 PM | 4:00 PM | Afternoon Coffee Break Sponsored by Synthego |
4:00 PM | 5:55 PM | Therapeutic Considerations Session Chairs: Jeffrey Quinn & Ben Kleinstiver |
4:00 PM | 4:25 PM | Invited Speaker: Human genetic diversity alters off-target outcomes of therapeutic gene editing, Luca Pinello, MGH |
4:25 PM | 4:50 PM | Invited Speaker: Defining and understanding the genome-wide off-target activity of CRISPR genome editors, Cicera Lazzarotto, Beam Therapeutics |
4:50 PM | 5:10 PM | Selected Abstract: Base Editing As a Genetic Treatment for Spinal Muscular Atrophy, Christiano Alves, MGH |
5:10 PM | 5:30 PM | Selected Abstract: Modulating Nucleotide Metabolism Enhances Prime Editing in Hematopoietic Stem and Progenitor Cells, Sebastien Levesque, Boston Children's Hospital |
5:30 PM | 5:55 PM | Invited Speaker: Why in vivo somatic editing must be a priority for low- and middle-income countries, Kiran Musunuru, UPenn |
October 19, 2023 | All Eastern Standard Time | |
Day 3 | ||
8:30 AM | 4:00 PM | Registration |
9:00 AM | 9:10 AM | Welcome Remarks by Chair: Benjamin Kleinstiver, Harvard |
9:10 AM | 10:00 AM | KEYNOTE: A Platform Approach to Develop and Deploy CRISPR-Cas Based Experimental Therapies for Inborn Errors of Immunity in an Academic/Nonprofit Setting, Fyodor Urnov, IGI |
10:00 AM | 10:30 AM | Morning Coffee Break |
10:30 AM | 12:25 PM | Structural Biology and Synthetic Biology Session Chairs: Jonathan Strecker & Ben Kleinstiver |
10:30 AM | 10:55 AM | Invited Speaker: Mechanism of RNA-guided and RNA-independent DNA integration by type V-K CRISPR-associated transposons, Jung-un Park, Cornell University |
10:55 AM | 11:20 AM | Invited Speaker: Next-generation continuous evolution technologies to create custom biomolecules, Ahmad Khalil, Boston University |
11:20 AM | 11:45 AM | Invited Speaker: RNA-guided DNA cleavage mechanism by IscB鈥愊塕NA, and efforts to improve its genome editing efficiency, Ailong Ke, Cornell University |
11:45 AM | 12:05 PM | Selected Abstract: Engineering Activatable Promoters for Deep, Wide, and Conditional CRISPRa/i Circuits, Diego Alba Burbano, University of Washington |
12:05 PM | 12:25 PM | Selected Abstract: Development of Compact Transcriptional Effectors Using High-Throughput Measurements in Diverse Contexts, Josh Tycko, Harvard Medical School |
12:25 PM | 1:25 PM | Lunch |
1:25 PM | 2:55 PM | Genome Editing Technologies for Small Sequence Edits Session Chairs: Jeffrey Quinn & Andrew Anzalone |
1:25 PM | 1:50 PM | Invited Speaker: Engineered CRISPR Technologies to Improve Genome Editing, Benjamin Kleinstiver, Harvard University |
1:50 PM | 2:15 PM | Invited Speaker: Andrew Anzalone, Prime Medicine |
2:15 PM | 2:35 PM | Selected Abstract: Click-to-Install Genome Editing Using RNA-Programmable DNA-Dependent Polymerases and HUH Endonucleases, Joana Ferreira da Silva, MGH/Harvard, Connor Tou, MGH/MIT |
2:35 PM | 2:55 PM | Selected Abstract: DNA Cryptography in Living Cells through Multi-Site Base Editing, Verena Volf, Harvard Medical School |
2:55 PM | 3:25 PM | Afternoon Coffee Break |
3:25 PM | 5:20 PM | Genome Editing Technologies for Large Sequence Edits Session Chairs: Andrew Anzalone & Ben Kleinstiver |
3:25 PM | 3:50 PM | Invited Speaker: Programmable molecular technologies for genome editing and cell control, Omar Abudayyeh, MIT & Jonathan Gootenberg, MIT |
3:50 PM | 4:15 PM | Invited Speaker: Structure and engineering of LINE retrotransposons, Max Wilkinson, MIT |
4:15 PM | 4:40 PM | Invited Speaker: Molecular requirements for CRISPR RNA-guided transposition, Matt Walker, Columbia University |
4:40 PM | 5:00 PM | Selected Abstract: Programmable Multi-Kilobase RNA Editing Using CRISPR-Mediated Trans-Splicing, Basem Al-Shayeb, Amber Bio, Inc. |
5:00 PM | 5:20 PM | Selected Abstract: Phage-Assisted Evolution and Protein Engineering Yield Compact, Efficient Prime Editors, Smriti Pandey, Harvard University/ The Broad Institute |
5:20 PM | 5:35 PM | Closing Remarks by Chairs: Kristin Knouse, MIT, Andrew Anzalone, Prime Medicine, & Benjamin Kleinstiver, Harvard |